Regulatory & Legal

Apnimed has secured up to $150M to launch AD109, a potential first-ever pill for sleep apnea, promising relief for millions tired of CPAP machines.

With record revenue and A-list fans, British MedTech firm LYMA is doubling down on the US market, blending clinical data with celebrity appeal.

Grubhub is offering a $100K 'Fee Return' to ease tax season stress, but is it real relief or a clever ploy in the competitive food delivery wars?

A key summit will dissect Vietnam's plan to navigate US tariffs and Mideast conflict while pursuing its ambitious goal of becoming a high-income nation.

GTA municipalities could save millions and slash emissions by using recycled road materials, but outdated local policies are blocking the path forward.

A legal battle erupts in Nevada as Getchell Gold Corp. defends its Fondaway Canyon project against a rival's claim on its most valuable ground.

A global health leader is running for Congress in a crowded NYC primary, betting her scientific expertise can beat traditional politics.

With ex-Sierra Space CEO Tom Vice at the helm, Astrion signals a bold new era, aiming to disrupt the national security and space markets.

After a years-long fight, a major airline caterer admits to violating worker rights, settling a key NLRB case and revealing a pattern of abuses.

Biopharma firm GENFIT sees soaring Iqirvo sales and a cash runway past 2028, overshadowing a net loss driven by strategic, non-cash write-downs.

MFS postpones a key shareholder vote on a major municipal fund merger, offering a tender to sway investors as Aberdeen prepares to take the helm.

In a major strategic shift, the new Bed Bath & Beyond acquires The Container Store and Elfa, aiming to build a dominant home organization and services empire.

A new partnership links Central Indiana's top pickleball clubs to a Major League Pickleball champion, creating a new path for aspiring pros.

A federally funded project aims to recycle 100,000 tons of used nuclear fuel, promising to slash waste and create a new domestic energy source.

A new partnership brings FDA-cleared eye-tracking tech to more providers, promising to cut year-long waits for autism diagnosis to mere minutes.

Taiwan's PharmaEssentia is building a new U.S. facility in Puerto Rico, a move set to bolster drug supply chains and deepen US-Taiwan economic ties.

A $10M investment from BVF Partners propels Entera Bio’s revolutionary oral osteoporosis drug into a pivotal Phase 3 trial, a major step for patients.

A pivotal clinical trial for PMM2-CDG, a devastating genetic disorder with no approved treatments, has completed enrollment, offering hope to thousands.

A massive 1GW+ AI data center in Texas will use innovative CO2 battery tech to create its own power, tackling grid strain and setting a new energy model.

Trailblazing public defender Cuauhtémoc Ortega joins an elite boutique, a move signaling a major shift in LA's high-stakes litigation landscape.